CARDIOVASCULAR IMAGING TECHNOLOGIES, LLC

Cardiovascular Imaging Technologies, LLC (CVIT) develops and distributes advanced cardiac imaging software solutions for PET and SPECT myocardial perfusion analysis. The company's flagship product, ImagenQ 3.0, is a quantitative myocardial blood flow analysis platform designed for rapid, automated processing of cardiac PET imaging data. ImagenQ 3.0 delivers end-to-end analysis in under 60 seconds with robust quality control tools including ROI assessment, splenic shut-off detection, and arterial input function curve analysis. The software supports multiple PET tracers (Rb-82, N-13 ammonia, F-18 flurpiridaz) and is compatible with most PET/CT systems and image review platforms. CVIT also supplies the Cedars Cardiac Suite, an established standard for PET and SPECT myocardial perfusion imaging. The company provides comprehensive technical support, clinical training, and research laboratory services to support clinical trial endpoints and advance nuclear cardiology imaging. CVIT maintains an in-house imaging core lab staffed by internationally recognized nuclear medicine professionals and operates a real-time support model emphasizing direct clinician access to technical expertise. The company serves hospital nuclear medicine departments, cardiovascular centers, and research institutions performing cardiac imaging and myocardial perfusion studies.